Nicholas Investment Partners, LP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nicholas Investment Partners, LP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,227,000
-77.4%
129,050
-54.8%
0.09%
-74.7%
Q4 2021$5,430,000
-66.4%
285,809
-41.2%
0.34%
-70.8%
Q3 2021$16,169,000
-36.9%
485,838
-26.5%
1.18%
-26.6%
Q2 2021$25,639,000
-15.0%
660,964
+5.6%
1.61%
-23.5%
Q1 2021$30,163,000
-7.7%
625,787
-0.4%
2.10%
-16.7%
Q4 2020$32,678,000
+432.2%
628,172
+173.8%
2.52%
+280.1%
Q3 2020$6,140,000229,4520.66%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RA Capital Management 6,880,323$38,633,0002.30%
Eversept Partners, LP 773,501$4,343,2081.35%
Opaleye Management Inc. 612,500$3,439,0001.24%
BRIDGER MANAGEMENT, LLC 2,334,196$13,107,0001.08%
Sofinnova Investments, Inc. 1,733,628$9,734,0000.88%
PURA VIDA INVESTMENTS, LLC 354,719$1,992,0000.34%
683 Capital Management, LLC 400,000$2,246,0000.25%
NEXPOINT ASSET MANAGEMENT, L.P. 649,460$3,646,0000.23%
Artal Group S.A. 900,000$5,054,0000.20%
Frontier Wealth Management LLC 226,750$1,273,0000.19%
View complete list of TG THERAPEUTICS INC shareholders